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Abstract The cysteine residues of the ABC protein MalK from
Salmonella typhimurium maltose transport system (C40, C350,
C360) were consecutively replaced by serines. Cys-less MalK
was fully functional in maltose transport in vivo. Moreover, the
activity of MalK as a repressor of other maltose-regulated genes
was also retained. The absence of cysteine residues in the purified
protein was verified by its failure to react with fluorescein-5-
maleimide. In contrast to purified wild-type MalK, the ATPase
activity of the C40S variant was insensitive to inhibition by N-
ethylmaleimide.
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1. Introduction
In enterobacteria, such as Escherichia coli and Salmonella
typhimurium, the uptake of maltose and maltodextrins is ac-
complished by a binding protein-dependent transport system
that is a member of the ATP binding cassette (ABC) super-
family of proteins [1]. The membrane-associated complex is
composed of one copy each of the hydrophobic subunits
MalF and MalG, that presumably form a translocation pore
[2], and of two copies of the ATP-hydrolyzing subunit (also
referred to as ABC protein) MalK, that is thought to provide
the energy for the transport process [3]. MalK is characterized
by a typical set of Walker A and B motifs that are suggested
to constitute a nucleotide binding fold [4]. In addition, and
unique to this subclass of ABC transporters, an extracellular
(periplasmic) substrate binding protein (MalE) is also required
for activity. It is proposed that the presence of substrate is
signalled by maltose-loaded binding protein via interaction
with externally exposed peptide loops of MalF/MalG. As a
consequence, conformational changes of the latter are trans-
mitted to the MalK subunits which, in turn, become activated.
Hydrolysis of ATP would then trigger subsequent conforma-
tional changes that eventually lead to the translocation of the
substrate molecule [5]. Besides being indispensable for the
transport process, MalK exhibits additional regulatory func-
tions. The protein is the target for unphosphorylated enzyme
IIAGlc of the phosphoenolpyruvate phosphotransferase system
in the process of inducer exclusion [6] and also acts as a
repressor of genes belonging to the maltose regulon [7,8].
The latter activity has been largely attributed to the car-
boxy-terminal domain of MalK [8^11] (Fig. 1). Although
the molecular basis of the repressing function is currently
not understood, evidence in support of a direct interference
with the positive regulator of the maltose system, MalT, has
been presented [7]. Thus, the various functions of MalK in
transport and regulation require speci¢c protein-protein inter-
actions the chemical nature of which are only beginning to
emerge. Analysis of suppressor mutations suggested that in
the assembled MalFGK2 complex MalK might interact with
MalF/MalG via a peptide fragment connecting the Walker A
and B motifs (‘helical domain’) [12,13]. Moreover, the analysis
by Mourez et al. [13] also revealed that conserved cytoplasmic
peptide loops of MalF and MalG (referred to as ‘EAA loop’)
might be in contact with the helical domain. Most recently,
reconstitution experiments provided ¢rst biochemical evidence
supporting the involvement of the helical domain in subunit-
subunit interactions in the complex [14]. In order to identify
individual amino acid residues from both the helical domain
and the EAA loops of MalF/MalG that might be in close
physical contact to each other, we intend to use site-directed
chemical crosslinking. In particular, introduction of cysteine
residues and subsequent analysis of disul¢de bond formation
has proven to be a powerful tool in elucidating neighboring
residues in proteins in the absence of a crystal structure [15^
17]. The construction of a Cys-less variant of MalK that has
retained its functions in transport and regulation is a prereq-
uisite for such a study. MalK contains three native cysteine
residues at positions 40, 350, and 360, respectively (Fig. 1).
C40 is located within the Walker A motif and, as revealed by
database searches, is almost invariant in the subfamily of
MalK-related ABC proteins (present in 23 out of 24 sequen-
ces). In other ABC proteins a cysteine residue is also fre-
quently found at that position. C350 and C360 are both lo-
cated in the carboxy-terminal extension of MalK that is
unique to members of the MalK subfamily (see also [12]).
Although the degree of sequence identity between the proteins
is signi¢cantly less pronounced in this region, C350 is found
within a conserved short sequence motif (consensus:
RCHLFD) of yet unknown function. In contrast, no cysteine
residue corresponding to C360 is present in other MalK-like
proteins listed in the database to date. Here, we report on the
functional consequences of consecutively replacing the native
cysteine residues of MalK by serines. Our results clearly dem-
onstrate that the Cys-less variant is fully active in transport
and also has retained the repressing activity. Moreover, we
show that the previously observed inhibition of the MalK
ATPase activity by N-ethylmaleimide [18] is due to modi¢ca-
tion of C40.
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2. Materials and methods
2.1. Bacterial strains
E. coli strain JM109 (Stratagene) was used for general cloning pur-
poses. Complementation and transport studies were performed using
S. typhimurium strain ES25 (dhuA1 vhisF645 malK786 galE503
recA56) that lacks a functional malK gene as a host [9]. The regulatory
activity of MalK variants was analyzed in E. coli strain SK1280
(MC4100 3[malK: :lacZ] hyb1113 recA) [8] as described in [11].
BL21DE3(pLysS) (Stratagene) was used as a host for overexpression
of malK alleles under the control of the T7 promoter.
2.2. Plasmids
Plasmid pSW7 carries the malK wild-type allele on pSE380 down-
stream of the trc promoter [19]. Derivatives of pSE380 carrying the
mutant alleles malK796 (C40S), malK797 (C40S/C350S), malK798
(C40S/C350S/C360S), malK812 (C360S), and malK826 (C350S) were
designated pSH25, pSH27, pSH39, pSH33, and pCB1, respectively.
Plasmids pES67 and pSH31 carry the malK wild-type allele and the
malK796 allele, respectively, on expression vector pRSET5d down-
stream of the T7 promoter [20]. Plasmids pGS91-1 (Schmees and
Schneider, unpublished) and pSH53 carry the malK wild-type allele
and the malK798 allele, respectively, on the his-tag fusion vector
pQE9 (Qiagen).
2.3. DNA techniques
Site-directed mutagenesis using Stratagene’s QuikChange protocol
or a PCR-based method (for pCB1 only) [21] was done with pSW7 as
template vector. Oligonucleotide primers were purchased from MWG-
Biotech (Freiburg). Introduced base changes were con¢rmed by nu-
cleotide sequence analysis.
2.4. Biochemical methods
The uptake of [14C]maltose (3.7 MBq ml31, ICN) in cells of strain
ES25 harboring the described plasmids, and SDS-PAGE were per-
formed as described in [9]. The MalKC40S variant was puri¢ed
from the overproducing strain BL21DE3(pSH31, pLysS) according
to [20]. The Cys-less variant of MalK was prepared as urea-soluble
fraction from the low speed pellet of strain JM109(pSH53) after cell
disrupture, as described in [22]. Wild-type protein was prepared by
both procedures using the overproducing strains BL21DE3(pES67,
pLysS) and JM109(pGS91-1), respectively. ATP hydrolysis was as-
sayed by monitoring the release of inorganic phosphate from [Q-
32P]ATP (424 MBq ml31, Amersham) as described previously [22].
3. Results and discussion
The native cysteine residues of MalK (C40, C350, C360)
were consecutively replaced by serine residues using site-di-
rected mutagenesis. The resulting plasmids carrying the mu-
tant malK alleles malK796 (C40S), malK826 (C350S), malK812
(C360S), malK797 (C40S/C350S), or malK798 (C40S/C350S/
C360S) were subsequently analyzed for their capability to re-
store maltose transport activity in S. typhimurium strain ES25
that lacks a functional malK gene [9]. As shown in Fig. 2, all
transformants displayed initial rates of [14C]maltose uptake
comparable to wild-type. Thus, none of the native cysteine
residues, including the highly conserved C40, is essential for
transport. This result con¢rms the recent ¢nding that a C40G
mutation did not a¡ect transport activity of the E. coli MalK
protein either [23].
Linker mutagenesis of the E. coli malK gene has recently
revealed that insertion of a hydrophilic peptide after positions
346 or 364 abolished the repressing activity of MalK while an
insertion after position 361 did not [10]. However, as the
authors pointed out, the e¡ect of the insertion after residue
364 might be caused by a structural alteration. Consequently,
we have analyzed the implications of Cys to Ser mutations at
positions 350 and 360 on this activity. To this end, plasmids
encoding the MalK variants were introduced into E. coli
strain SK1280. This strain carries a chromosomal malK-lacZ
fusion that results in a maltose-negative phenotype but places
the lacZ gene under the control of the pmalK promoter [8].
Thus, the repressing activities of plasmid-encoded MalK var-
iants are conveniently monitored by assaying the L-galactosi-
dase activity of the cells. In the presence of the vector plasmid
(pSE380), full enzymatic activity was obtained, while a plas-
mid carrying the malK wild-type allele (pSW7) caused repres-
sion of the fusion gene (Fig. 3). As demonstrated in Fig. 3, the
L-galactosidase activities measured with any of the variants
compared favorably to that observed with wild-type. These
results clearly indicate that both C-terminally located cysteine
residues are dispensable for the regulatory function of MalK.
Whether other residues of the short sequence motif encom-
passing C350 (RCHLFD, see Section 1) are essential for this
activity remains to be elucidated.
To determine that the MalK variant encoded by the
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Fig. 1. Linear representation of MalK, with the assignment of puta-
tive functional domains (modi¢ed from [12]). The relative positions
of the nucleotide binding motifs A and B, and of the native cysteine
residues that were replaced by serines in this study are indicated.
For further details, see text and references [11,12].
Fig. 2. E¡ect of cysteine to serine mutations on maltose transport.
Cells of S. typhimurium strain ES25 (malK) harboring the described
plasmids were grown in nutrient broth, supplemented with 0.5%
maltose, to A650 = 1, washed twice in minimal salts, and immediately
analyzed for maltose uptake as described in [9]. b, MalK wild-type
(pSW7); E, C40S (pSH25); F, C350S (pCB1); P, C360S (pSH33);
O, C40S/C350S (pSH27); 8, C40S/C350S/C360S (pSH30); a,
(plasmid vector pSE380). Means of three experiments are shown.
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malK798 allele was indeed devoid of cysteine residues, label-
ling experiments were carried out with the cysteine speci¢c
reagent £uorescein-5-maleimide to directly monitor modi¢ca-
tion of the protein. Wild-type and ‘Cys-less’ MalK prepared
from the low speed pellet fractions of the overproducing
strains JM109(pGS91-1) and JM109(pSH53), respectively, by
solubilization with 8 M urea were incubated with £uorescein-
5-maleimide and subjected to SDS-PAGE. As shown in Fig.
4, visualization of the gel under UV light revealed modi¢ca-
tion of the wild-type protein that could be prevented by pre-
incubation with N-ethylmaleimide (NEM). In contrast, the
reagent failed to modify the Cys-less variant, thereby strongly
indicating that the protein was lacking any cysteine residue.
We have recently shown that the puri¢ed MalK protein
exhibits a spontaneous ATPase activity that is inhibited by
NEM [18]. Since inhibition was blocked by preincubation
with ATP, Cys-40, that is located within the nucleotide bind-
ing motif A (GPSGCGKST; see also Fig. 1) was proposed to
be the likely candidate for modi¢cation. This view was sup-
ported by the ¢nding that modi¢cation of the corresponding
cysteine residues in either of the two nucleotide binding do-
mains inhibited the ATPase activity of P-glycoprotein, a
mammalian member of the ABC transport family involved
in multi-drug resistance [24]. The ATPase activity of HisP,
another bacterial homolog of MalK, was also reported to
be sensitive to NEM [25]. Interestingly however, the protein
is lacking a cysteine residue within the Walker A motif. The
authors speculated on a carboxy-terminally located cysteine
residue (C51) as the possible target, although this residue is
not involved in the interaction with ATP as revealed from the
recently determined crystal structure of HisP [26]. Thus, in
order to clarify the role of Cys-40 in the inhibition of MalK
ATPase activity by NEM, the MalKC40S variant was puri¢ed
from strain BL21DE3(pLysS, pSH31) by a published proce-
dure [20], and analyzed for its capability to hydrolyze ATP in
the presence and absence of NEM. As demonstrated in Fig. 5
and con¢rming recent results, 20 WM NEM caused substantial
inhibition (s 80%) of the catalytic activity of the wild-type
protein. In contrast, under the same conditions the ATPase
activity of the MalKC40S variant was basically insensitive to
the inhibitor. These results are fully consistent with the notion
that the observed loss of enzymatic activity in the presence of
NEM is caused by covalent modi¢cation of C40. Moreover,
while the cysteine residue as such is dispensable for function,
the introduction of a bulky group probably prevents ATP
from getting proper access to the nucleotide binding fold
and thus, is not tolerated. This view is supported by the crys-
tal structure of HisP which demonstrated the formation of a
hydrogen bond between the main-chain nitrogen of S43 (cor-
responding to C40 in MalK) and the L-phosphate of ATP
[26].
Taken together, we have shown that the native cysteine
residues of MalK can be replaced by serines without a¡ecting
functions. The Cys-less variant can thus be subjected to site-
directed chemical modi¢cation in order to elucidate subunit-
subunit interactions in the transport complex. Such studies are
in progress in this laboratory.
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Fig. 5. E¡ect of N-ethylmaleimide on ATPase activity of puri¢ed
MalK variants. Native MalK (WT) and MalKC40S (10 Wg each)
were incubated with 20 WM NEM in assay bu¡er for 15 min at
room temperature and subsequently analyzed for ATPase activity
by monitoring the release of phosphate from [Q-32P]ATP as de-
scribed in [22]. The data represent the means of two independent ex-
periments. Standard deviations are indicated by error bars. Note
that the somewhat lower ATPase activity of the wild-type was a
property of the particular preparation used. The C40S mutation did
not cause an increase in enzymatic activity.
Fig. 3. E¡ect of serine for cysteine substitutions on the regulatory
activity of MalK. Cells of E. coli strain SK1280, harboring the de-
scribed plasmids were grown in Luria broth to A600 = 0.4, and sub-
sequently analyzed for L-galactosidase activity as described in [11].
The data represent the means of two independent experiments.
Standard deviations are indicated by error bars.
Fig. 4. Modi¢cation of MalK variants with £uorescein-5-maleimide.
Urea-solubilized native and Cys-less MalK (6 Wg each) were incu-
bated with £uorescein-5-maleimide (Pierce) (0.5 mM) for 10 min on
ice and subsequently subjected to SDS-PAGE. Labelling was visual-
ized under UV light (A) prior to protein staining with Coomassie
brilliant blue (B). Preincubation with NEM (0.5 mM) was per-
formed for 1 h on ice. Lanes: 1, wild-type (+NEM); 2, wild-type
(3NEM); 3, Cys-less (+NEM); 4, Cys-less (3NEM).
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